首页> 外文学位 >Computational studies of the metal-binding proteins stromelysin-1 and human serum transferrin: Protein modeling and inhibitor design.
【24h】

Computational studies of the metal-binding proteins stromelysin-1 and human serum transferrin: Protein modeling and inhibitor design.

机译:金属结合蛋白stromelysin-1和人血清转铁蛋白的计算研究:蛋白质建模和抑制剂设计。

获取原文
获取原文并翻译 | 示例

摘要

This study constitutes a detailed molecular modeling investigation of two metal-binding proteins: stromelysin-1 (MMP-3), a matrix metalloproteinase, and human serum transferrin. Matrix metalloproteinases (MMPs) comprise a family of zinc-binding enzymes responsible for connective tissue remodeling; they mediate the breakdown of extracellular matrix proteins such as collagen, gelatin and proteoglycan. MMPs have been identified in tissue surrounding invasive carcinoma, and directly enable tumor metastasis through proteolysis and blood vessel formation (angiogenesis). Degenerative and inflammatory diseases such as osteoarthritis also depend on MMPs to spread to unaffected tissue. These enzymes are therefore attractive targets for small-molecule synthetic inhibitors (MMPIs) which would serve as adjuncts to traditional treatments such as radiation and chemotherapy. Comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis (CoMSIA), widely used 3D paradigms of quantitative structure-activity relationship (QSAR) models, are useful when the binding area is unknown or difficult to model, and are therefore well suited to MMPI design. Three highly predictive CoMFA models, and one predictive CoMSIA model, have been derived and applied to the design of a new series of nonpeptidic, thalidomide-based MMPIs which demonstrate high predicted biological activity against stromelysin-1 (MMP-3).; Human serum transferrin (HST) is an approximately 80-kDa iron-binding glycoprotein responsible for transporting iron(III) cations from erythrocyte processing locations to tissues that require iron. HST is normally ∼30% saturated with Fe, but frequent blood transfusions can result in toxic iron overload, where HST becomes totally saturated and unable to remove excess iron from the bloodstream. The immediate therapeutic goal is to facilitate iron removal from HST in order to safely chelate and excrete it; this is complicated by the extremely slow iron release process. Certain anions selectively affect Fe release from HST and are believed to bind at one or more allosteric “KISAB” (kinetically significant anion-binding) sites. Probable KISAB sites have been identified and rank-ordered using a unique three-stage computational process incorporating energy grid calculations, molecular dynamics, and molecular mechanics.
机译:这项研究构成了两种金属结合蛋白的详细分子模型研究:Stromelysin-1(MMP-3),基质金属蛋白酶和人血清转铁蛋白。基质金属蛋白酶(MMP)包含一族负责结缔组织重塑的锌结合酶。它们介导诸如胶原蛋白,明胶和蛋白聚糖的细胞外基质蛋白的分解。 MMP已在浸润癌周围的组织中鉴定出来,并通过蛋白水解和血管形成(血管生成)直接使肿瘤转移。退化性和炎性疾病(例如骨关节炎)也取决于MMP扩散到未受影响的组织。因此,这些酶是小分子合成抑制剂(MMPI)的有吸引力的靶标,它们可作为传统疗法(例如放射疗法和化学疗法)的辅助剂。比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)是广泛使用的定量结构-活性关系(QSAR)模型的3D范式,当结合面积未知或难以建模时非常有用,因此非常有用适用于MMPI设计。已推导了三种高度预测性的CoMFA模型和一种预测性的CoMSIA模型,并将其用于一系列新的基于非肽类,沙利度胺的MMPIs的设计,这些MMPIs表现出对溶血素-1(MMP-3)的高预测生物学活性。人血清转铁蛋白(HST)是大约80 kDa的铁结合糖蛋白,负责将铁(III)阳离子从红细胞加工位置转运到需要铁的组织。 HST通常被铁饱和约30%,但是频繁的输血会导致有毒的铁超载,使HST完全饱和,无法从血流中去除多余的铁。近期的治疗目标是促进从HST中去除铁,以便安全地螯合和排泄它。铁释放过程非常缓慢,这使情况变得复杂。某些阴离子选择性地影响Fe从HST释放,并据信在一个或多个变构“ KISAB”(动力学上重要的阴离子结合)位点结合。已使用独特的三阶段计算过程(包括能量网格计算,分子动力学和分子力学)识别了可能的KISAB站点并对其进行了排序。

著录项

  • 作者

    Amin, Elizabeth Ambrose.;

  • 作者单位

    University of Missouri - Saint Louis.;

  • 授予单位 University of Missouri - Saint Louis.;
  • 学科 Chemistry Biochemistry.; Chemistry Physical.; Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2002
  • 页码 p.4006
  • 总页数 244
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号